GRML$4.15+4.01%
Greenland Mines Ltd
Sector: Biological Products, (No Diagnostic Substances)Industry: Other Precious MetalsCountry: USExchange: Nasdaq
Mkt Cap:$56.8M
Float & O/S:
Inst Own:
DilutionScan read 42 of Greenland Mines Ltd's SEC filings and found 7 warrant series, 7 convertibles, 2 ATM programs, 1 shelf registration, 3 S-1 registrations and 5 completed offerings on file for GRML. The latest dilution event on file is a registration statement on Oct 26, 2026. Analysis updated Oct 26, 2026.
Signal8 Summary
GRML
Going-concern warning, extreme dilution
Snapshot
GRML is a pre-revenue mining explorer (plus a small legacy biotech arm) that lost $10.6M in FY 2025 and burned $5.9M in free cash flow with zero revenue.
What's Happening Right Now
- : GRML raised over $17M more on Sept 29, 2026, bringing total new capital to over $59M in a week, and added two mining directors to the board.
- : On Sept 24, 2026, GRML completed a $42M equity raise at $12/share, terminated its ATM program, and finished its 2026 Sarfartoq rare earth field program.
- : Issued warrants over 1.43M shares.
- : Sold $1.39M of stock through its at-the-market program.
- : GRML's Q2 2026 10-Q disclosed a $17.5M six-month net loss on zero revenue, explicit going-concern doubt, and a share count that had more than doubled since December 2025.
- : On Sept 1, 2026, GRML closed its acquisition of the Sarfartoq Nd-Pr rare earths project for $20M cash plus $15M in stock, with Neo Performance Materials taking offtake rights.
- : Closed an offering. Proceeds are not disclosed in the filings reviewed.
- : On Aug 20, 2026, GRML announced a 1-for-50 reverse stock split to regain Nasdaq compliance after its share price fell below $1.
